Orion Oyj (ADR)
General ticker "ORINY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $20.7B (TTM average)
Orion Oyj (ADR) follows the US Stock Market performance with the rate: 21.1%.
Estimated limits based on current volatility of 0.0%: low 37.99$, high 37.99$
Factors to consider:
- Company pays dividends (annually): last record date 2026-03-26, amount 0.53$ (Y1.40%)
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [28.35$, 41.87$]
- 2026-12-31 to 2027-12-31 estimated range: [29.98$, 43.94$]
Financial Metrics affecting the ORINY estimates:
- Positive: with PPE of 17.5 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 33.43 > 18.52
- Positive: Investing cash flow per share per price, % of -0.58 > -0.65
- Positive: Industry inventory ratio change (median), % of 0.11 <= 0.31
- Positive: Industry operating profit margin (median), % of 26.76 > 9.67
- Positive: Industry earnings per price (median), % of 6.05 > 4.54
- Positive: 5.46 < Industry operating cash flow per share per price (median), % of 6.51
- Positive: 0.07 < Operating cash flow per share per price, % of 1.85
- Positive: Return on assets ratio (scaled to [-100,100]) of 19.30 > 6.12
Short-term ORINY quotes
Long-term ORINY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €1,189.70MM | €1,542.40MM | €1,889.50MM |
| Operating Expenses | €914.80MM | €1,125.80MM | €1,257.90MM |
| Operating Income | €274.90MM | €416.60MM | €631.60MM |
| Non-Operating Income | €-3.00MM | €-3.50MM | €-3.80MM |
| Interest Expense | €5.20MM | €7.60MM | €8.36MM |
| R&D Expense | €126.90MM | €179.60MM | €210.40MM |
| Income(Loss) | €271.90MM | €413.10MM | €627.80MM |
| Taxes | €55.10MM | €0.00MM | €127.50MM |
| Profit(Loss)* | €216.80MM | €329.90MM | €480.55MM |
| Stockholders Equity | €890.10MM | €1,005.00MM | €1,284.50MM |
| Inventory | €362.20MM | €418.60MM | €456.30MM |
| Assets | €1,438.60MM | €1,629.10MM | €2,009.90MM |
| Operating Cash Flow | €119.00MM | €293.40MM | €316.80MM |
| Capital expenditure | €116.80MM | €86.90MM | €97.60MM |
| Investing Cash Flow | €-108.40MM | €-85.20MM | €-98.60MM |
| Financing Cash Flow | €-243.20MM | €-108.80MM | €-263.60MM |
| Earnings Per Share** | €0.77 | €1.17 | €0.85 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.